Page last updated: 2024-09-03

elacridar and wk-x-34

elacridar has been researched along with wk-x-34 in 1 studies

Compound Research Comparison

Studies
(elacridar)
Trials
(elacridar)
Recent Studies (post-2010)
(elacridar)
Studies
(wk-x-34)
Trials
(wk-x-34)
Recent Studies (post-2010) (wk-x-34)
28481191003

Protein Interaction Comparison

ProteinTaxonomyelacridar (IC50)wk-x-34 (IC50)
ATP-dependent translocase ABCB1Homo sapiens (human)0.3342
Broad substrate specificity ATP-binding cassette transporter ABCG2Homo sapiens (human)1.2931

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Müller, H; Pick, A; Wiese, M1

Other Studies

1 other study(ies) available for elacridar and wk-x-34

ArticleYear
Novel lead for potent inhibitors of breast cancer resistance protein (BCRP).
    Bioorganic & medicinal chemistry letters, 2010, Jan-01, Volume: 20, Issue:1

    Topics: ATP Binding Cassette Transporter, Subfamily G, Member 2; ATP-Binding Cassette Transporters; Benzamides; Benzimidazoles; Cell Line, Tumor; Chlorophyll; Humans; Molecular Conformation; Neoplasm Proteins; Phenylurea Compounds; Small Molecule Libraries

2010
chemdatabank.com